Skip to search formSkip to main contentSkip to account menu

ruxolitinib 20 MG Oral Tablet

Known as: RUXOLITINIB 20MG TAB,ORAL, RUXOLITINIB 20MG ORAL TAB, ruxolitinib (as ruxolitinib phosphate) 20 MG Oral Tablet 
National Institutes of Health

Related topics

Related topics

2 relations
Oral Tabletruxolitinib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Les inhibiteurs de la voie des Janus-kinases : un traitement prometteur de la dermatomyosite pour inhiber de la voie de l’interféron
2015
2015
Ruxolitinib auch zur Therapie der Polycythaemia vera geeignet
Review
2013
Review
2013
Chronic Neutrophilic Leukemia With Concurrent CSF3R and SETBP1 Mutations: Single Colony Clonality Studies, In Vitro Sensitivity To JAK Inhibitors and Lack Of Treatment Response To Ruxolitinib
Background High frequency mutations in both the colony-stimulating factor 3 receptor ( CSF3R ) and SET binding protein-1 ( SETBP1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)